ОТНОСТНО ТОЗИ ЕПИЗОД

Английски
САЩ

ТРАНСКРИПЦИЯ 🔗

ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ

Търсене в минали епизоди на ASHP Advantage Podcasts.

ДРУГИ ЕПИЗОДИ В ТОЗИ ПОДКАСТ

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Phar…
In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity C…
William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care n…
William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Corn…
William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Corn…
Опровержение: Подкастът и произведенията на изкуството, вградени на тази страница, са от ASHP Advantage, което е собственост на неговия собственик и не е свързано с или одобрено от Listen Notes, Inc.